AIM ImmunoTech Valuation
| AIM Stock | USD 0.43 0.01 2.38% |
AIM ImmunoTech is overvalued. AIM ImmunoTech shows a prevailing Real Value of $0.38 per share. The current price of the firm is $0.43. Our model approximates the value of AIM ImmunoTech from examining the firm fundamentals such as Current Valuation of 9.57 M, operating margin of (215.45) %, and Return On Equity of -1.19 as well as evaluating its technical indicators and probability of bankruptcy. In general, most investors favor obtaining undervalued instruments and abandoning overvalued instruments since, in the future, asset prices and their ongoing real values will blend. Key fundamental drivers impacting AIM ImmunoTech's valuation include:
Price Book 2.9381 | Enterprise Value 9.6 M | Enterprise Value Ebitda (0.52) | Price Sales 138.834 | Enterprise Value Revenue 81.0963 |
Overvalued
Today
Please note that AIM ImmunoTech's price fluctuation is out of control at this time. Calculation of the real value of AIM ImmunoTech is based on 3 months time horizon. Increasing AIM ImmunoTech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for AIM ImmunoTech is useful when determining the fair value of the AIM stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of AIM ImmunoTech. Since AIM ImmunoTech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AIM Stock. However, AIM ImmunoTech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.43 | Real 0.38 | Target 3.83 | Hype 0.43 | Naive 0.34 |
The real value of AIM Stock, also known as its intrinsic value, is the underlying worth of AIM ImmunoTech Company, which is reflected in its stock price. It is based on AIM ImmunoTech's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of AIM ImmunoTech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence AIM ImmunoTech's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of AIM ImmunoTech helps investors to forecast how AIM stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AIM ImmunoTech more accurately as focusing exclusively on AIM ImmunoTech's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use AIM ImmunoTech's intrinsic value based on its ongoing forecasts of AIM ImmunoTech's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against AIM ImmunoTech's closest peers. When choosing an evaluation method for AIM ImmunoTech, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
AIM ImmunoTech Investments |
|
AIM Valuation Trend
Knowing AIM ImmunoTech's actual value is paramount for traders to make sound investment determinations. AIM ImmunoTech's real value is not only important for the investor to make better decisions but also for a more accurate overall view of AIM ImmunoTech's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both AIM ImmunoTech's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
AIM Market Cap
AIM ImmunoTech is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is presently estimated at about 1.98 Billion. AIM ImmunoTech claims roughly 21.59 Million in market capitalization contributing just under 2% to equities under Health Care industry.AIM ImmunoTech Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining AIM ImmunoTech's current stock value. Our valuation model uses many indicators to compare AIM ImmunoTech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AIM ImmunoTech competition to find correlations between indicators driving AIM ImmunoTech's intrinsic value. More Info.AIM ImmunoTech is rated second in price to earning category among related companies. It is rated below average in price to book category among related companies fabricating about 0.24 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for AIM ImmunoTech is roughly 4.25 . As of the 24th of April 2024, Price To Book Ratio is likely to drop to 1.98. Comparative valuation analysis is a catch-all model that can be used if you cannot value AIM ImmunoTech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AIM ImmunoTech's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AIM ImmunoTech's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates AIM ImmunoTech's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in AIM ImmunoTech and how it compares across the competition.
About AIM ImmunoTech Valuation
The stock valuation mechanism determines the current worth of AIM ImmunoTech on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of AIM ImmunoTech. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of AIM ImmunoTech based exclusively on its fundamental and basic technical indicators. By analyzing AIM ImmunoTech's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of AIM ImmunoTech's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of AIM ImmunoTech. We calculate exposure to AIM ImmunoTech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to AIM ImmunoTech's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -78 K | -81.9 K | |
| Pretax Profit Margin | (143.38) | (136.21) | |
| Operating Profit Margin | (157.93) | (150.03) | |
| Net Loss | (143.38) | (136.21) | |
| Gross Profit Margin | (0.39) | (0.41) |
8 Steps to conduct AIM ImmunoTech's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates AIM ImmunoTech's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct AIM ImmunoTech's valuation analysis, follow these 8 steps:- Gather financial information: Obtain AIM ImmunoTech's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine AIM ImmunoTech's revenue streams: Identify AIM ImmunoTech's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research AIM ImmunoTech's industry and market trends, including the size of the market, growth rate, and competition.
- Establish AIM ImmunoTech's growth potential: Evaluate AIM ImmunoTech's management, business model, and growth potential.
- Determine AIM ImmunoTech's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate AIM ImmunoTech's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
AIM ImmunoTech Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as AIM ImmunoTech does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 48.6 M |
AIM ImmunoTech Current Valuation Indicators
Valuation refers to the process of determining the present value of AIM ImmunoTech and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value AIM we look at many different elements of the entity such as AIM's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. AIM ImmunoTech's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final AIM ImmunoTech's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as AIM ImmunoTech, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use AIM ImmunoTech's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes AIM ImmunoTech's worth.When determining whether AIM ImmunoTech is a strong investment it is important to analyze AIM ImmunoTech's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AIM ImmunoTech's future performance. For an informed investment choice regarding AIM Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AIM ImmunoTech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in AIM Stock, please use our How to Invest in AIM ImmunoTech guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for AIM Stock analysis
When running AIM ImmunoTech's price analysis, check to measure AIM ImmunoTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AIM ImmunoTech is operating at the current time. Most of AIM ImmunoTech's value examination focuses on studying past and present price action to predict the probability of AIM ImmunoTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AIM ImmunoTech's price. Additionally, you may evaluate how the addition of AIM ImmunoTech to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
Is AIM ImmunoTech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AIM ImmunoTech. If investors know AIM will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AIM ImmunoTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.60) | Revenue Per Share 0.004 | Quarterly Revenue Growth 0.161 | Return On Assets (0.67) | Return On Equity (1.19) |
The market value of AIM ImmunoTech is measured differently than its book value, which is the value of AIM that is recorded on the company's balance sheet. Investors also form their own opinion of AIM ImmunoTech's value that differs from its market value or its book value, called intrinsic value, which is AIM ImmunoTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AIM ImmunoTech's market value can be influenced by many factors that don't directly affect AIM ImmunoTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AIM ImmunoTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if AIM ImmunoTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AIM ImmunoTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.